Q3 2024 totaled $5,400,000 compared to the prior year Q3 operating expenses of $6,600,000 The 18% period over period decrease is primarily driven by our cost containment efforts and focus on reducing selling, general and administrative expenses, specifically management's actions to reduce employee consultant and legal costs. Further, our investment in research and development of $2,200,000 in the quarter was in line with the $2,300,000 recognized in the 2023 quarter, which reflects our focus on innovation and continues to play a key role in driving future growth, particularly within our high performance computing platforms. The company reported a net loss attributable to common stockholders of $5,700,000 or $0.06 per basic share for the Q3 of 2024 compared to a net loss available to common shareholders of $7,100,000 or $0.10 per basic share for the same period of the previous year. Total assets at September 30, 2024 were 76,800,000 dollars which was up $2,400,000 from the $74,400,000 reported at December 31, 2023. Cash and cash equivalents at September 30, 2024 increased $1,000,000 from year end 2023 to approximately $3,100,000 In the Q3, the company had raised net proceeds of $7,000,000 in the secured convertible debt financing.